| Literature DB >> 23762051 |
Franciane Rocha Faria1, Eliane Rodrigues Faria, Roberta Stofeles Cecon, Djalma Adão Barbosa Júnior, Sylvia do Carmo Castro Franceschini, Maria do Carmo Gouveia Peluzio, Andréia Queiroz Ribeiro, Pedro Israel Cabral Lira, Paulo Roberto Cecon, Silvia Eloiza Priore.
Abstract
The aim of this study was to analyze body fat anthropometric equations and electrical bioimpedance analysis (BIA) in the prediction of cardiovascular risk factors in eutrophic and overweight adolescents. 210 adolescents were divided into eutrophic group (G1) and overweight group (G2). The percentage of body fat (% BF) was estimated using 10 body fat anthropometric equations and 2 BIA. We measured lipid profiles, uric acid, insulin, fasting glucose, homeostasis model assessment-insulin resistance (HOMA-IR), and blood pressure. We found that 76.7% of the adolescents exhibited inadequacy of at least one biochemical parameter or clinical cardiovascular risk. Higher values of triglycerides (TG) (P = 0.001), insulin, and HOMA-IR (P < 0.001) were observed in the G2 adolescents. In multivariate linear regression analysis, the % BF from equation (5) was associated with TG, diastolic blood pressure, and insulin in G1. Among the G2 adolescents, the % BF estimated by (5) and (9) was associated with LDL, TG, insulin, and the HOMA-IR. Body fat anthropometric equations were associated with cardiovascular risk factors and should be used to assess the nutritional status of adolescents. In this study, equation (5) was associated with a higher number of cardiovascular risk factors independent of the nutritional status of adolescents.Entities:
Year: 2013 PMID: 23762051 PMCID: PMC3670509 DOI: 10.1155/2013/501638
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Body fat and fat-free mass anthropometric equations.
| Reference | Sex | Equation | Equation number |
|---|---|---|---|
| Masc.a |
| ||
| Durnin and Rahaman (1967) [ | Fem.a |
| |
| % BF = [(4.95/ | (1) | ||
| Masc.b |
| ||
| Durnin and Womersley (1974) [ | Fem.b |
| |
| % BF = [(4.95/ | |||
|
| |||
| Masc. | % BF = 1.35 [triceps (mm) + subscapular (mm)] – 0.012 | ||
|
Boileau et al. (1985) [ | [triceps (mm) + subscapular (mm)]2 – 4.4 | (2) | |
| Fem. | % BF = 1.35 [triceps (mm) + subscapular (mm)] – 0.012 | ||
| [triceps (mm) + subscapular (mm)]2 – 2.4 | |||
|
| |||
| Masc. | % BF = 0.735 [triceps (mm) + calf (mm)] + 1.0 | (3) | |
| Masc.c | % BF = 1.21 [triceps (mm) + subscapular (mm)] – 0.008 | ||
|
Slaughter et al. (1988) [ | [triceps (mm) + subscapular (mm)]2 + | ||
| Fem.c | % BF = 1.33 [triceps (mm) + subscapular (mm)] – 0.013 | (4) | |
| [triceps (mm) + subscapular (mm)]2 – 2.5 | |||
| Masc.d
| % BF = 0.783 [triceps (mm) + subscapular (mm)] + 1.6 | ||
|
| |||
| Weststrate and Deurenberg (1989) [ | Masc. | % BF = ({562 − 4.2[ | (5) |
|
| |||
| Masc. | FFM = 0.646 (Wt) – 0.116 [lateral calf (mm)] – 0.375 | ||
|
Guo et al. (1989) [ | [midaxillary (mm)] + 0.475 [arm muscle |
(6) | |
| Fem. | FFM = 0.682 (Wt) – 0.185 [lateral calf (mm)] – 0.244 | ||
| [triceps (mm)] – 0.202 [subscapular (mm)] + 0.182 (Ht2/ | |||
|
| |||
| Deurenberg et al. (1990) [ | Masc. | % BF = 18.88 [log ( | (7) |
|
| |||
| Deurenberg et al. (1991) [ | Masc./Fem.e
| % BF = 1.51 (BMI) – 0.70 ( | (8) |
|
| |||
| Houtkooper et al. (1992) [ | Masc./Fem. | FFM = 0.61 (Ht2/ | (9) |
|
| |||
| Ellis (1997) [ | Masc.g
|
| (10) |
aEquation for adolescents aged 15-16 years; bequation for adolescents aged 17-18 years; c for a sum of triceps and subscapular skinfold thicknesses <35 mm; dfor a sum of triceps and subscapular skinfold thicknesses >35 mm; eequation for adolescents aged ≤15 years; fequation for adolescents aged ≥16 years; gequations for white individuals; hequations for black individuals; log∑4 skinfold thicknesses = logarithm sum of bicipital, tricipital, suprailiacal, subscapular skinfold thicknesses (mm); for boys aged 2–18 y: D † = {1.1315 + (0.0018[A − 2])} − {0.0719 − 0.0006[A − 2] × log(∑4 skin fold thicknesses)} and for girls aged 11–18 y: D † ={1.1350 + (0,0031[A − 10])} − {0.0719 − 0.0003[A − 2] × log(∑4 skin fold thicknesses)}; Eq: equation; Fem: feminine sex; Masc.: masculine sex; D: density (g/L); % BF: percentage of body fat; FFM: fat free mass (kg), R: resistance (Ω); A: age (years); F: fat (kg); BMI: body mass index (kg/m2); S: sex (masculine = 1 and feminine = 0); Wt: body weight (kg); Ht: height (cm); I: intercept in males varies for maturation level and racial group as follows: for black males: prepubescent = − 3.5; pubescent = − 5.2; postpubescent and adult = − 6.8. For white males: prepubescent = − 1.7; pubescent = − 3.4; postpubescent and adult = − 5.5.
Physical and metabolic characteristics of the adolescents according to studied group (Viçosa, Minas Gerais, Brazil (2010)).
| Parameters | Group | ||||
|---|---|---|---|---|---|
| G1 | G2 |
| |||
| Mean (SD) | Median (Min–Max) | Mean (SD) | Median (Min–Max) | ||
| Age (years) | 16.9 ± 1.0 | 16.9 (15.1–19.0) | 16.7 ± 1.0 | 18.9 (15.0–18.7) | 0.910a |
| Weight (kg) | 60.2 ± 6.1 | 59.8 (44.7–75.9) | 75.7 ± 13.7 | 72.9 (57.5–128.7) | <0.0001b |
| Height (cm) | 168.4 ± 8.2 | 168.5 (149.5–185.7) | 166.4 ± 10.3 | 165.4 (149.2–191.3) | 0.021a |
| BMI (kg/m2) | 21.2 ± 1.1 | 21.3 (18.7–23.6) | 27.2 ± 3.0 | 26.4 (23.1–40.1) | <0.0001b |
| Fasting glucose (mg/dL) | 84.0 ± 6.0 | 84.0 (69.0–99.0) | 84.7 ± 7.0 | 85.0 (71.0–98.0) | 0.082a |
| TC (mg/dL) | 146.6 ± 26.3 | 146.0 (83.0–271.0) | 152.0 ± 28.3 | 149.0 (87.0–252.0) | 0.945a |
| HDL (mg/dL) | 48.9 ± 11.0 | 48.0 (21.0–74.0) | 44.8 ± 10.7 | 43.0 (27.0–72.0) | 0.799a |
| LDL (mg/dL) | 85.1 ± 22.9 | 85.3 (44.8–202.8) | 90.0 ± 22.4 | 88.2 (40.2–148.6) | 0.819a |
| TC/HDL | 3.11 ± 0.75 | 3.04 (1.88–6.57) | 3.54 ± 0.93 | 3.44 (1.96–6.63) | 0.001b |
| LDL/HDL | 1.83 ± 0.63 | 1.75 (0.76–4.39) | 2.12 ± 0.73 | 2.05 (0.77–4.02) | 0.005b |
| TG (mg/dL) | 63.2 ± 26.9 | 60.0 (24.0–189.0) | 85.2 ± 53.3 | 76.0 (31.0–320.0) | 0.0001b |
| Uric Acid (mg/dL) | 3.7 ± 1.1 | 3.7 (1.5–7.4) | 3.8 ± 1.2 | 3.7 (1.6–7.5) | 0.980a |
| Insulin ( | 9.1 ± 3.6 | 9.0 (2.0–23.4) | 12.8 ± 5.6 | 11.2 (3.9–27.1) | <0.0001b |
| HOMA-IR | 1.9 ± 0.8 | 1.8 (0.4–4.6) | 2.7 ± 1.3 | 2.3 (0.8–6.4) | 0.0001b |
| SBP (mmHg) | 102.9 ± 8.2 | 102.8 (82.0–125.0) | 104.7 ± 9.3 | 104.0 (83.0–125.0) | 0.083a |
| DBP (mmHg) | 60.5 ± 7.9 | 61.5 (40.0–84.0) | 61.1 ± 8.7 | 61.0 (43.0–82.0) | 0.592a |
aStudent's t-test; bMann-Whitney test, SD: standard deviation, Min: minimum, Max: maximum, BMI: body mass index, TC: total cholesterol, HDL: high-density lipoprotein, LDL: low-lipoprotein density, TG: triglycerides, HOMA-IR: homeostasis model assessment-insulin resistance, SBP: systolic blood pressure, DBP: diastolic blood pressure.
Simple linear regression coefficient (β) and coefficient of determination (r 2) of the relationship between percentage of body fat and biochemical and clinical parameters in eutrophic adolescents (G1) (Viçosa, Minas Gerais, Brazil (2010)).
| Eq (1) | Eq (2) | Eq (3) | Eq (4) | Eq (5) | Eq (6) | Eq (7) | Eq (8) | Eq (9) | Eq (10) | BIA1 | BIA2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fasting glucose (mg/dL) |
| −0.23‡ | −0.27‡ | −0.26** | −0.21** | −0.26‡ | −0.19‡ | −0.26‡ | −0.44‡ | −0.25‡ | −0.26‡ | 0.25‡ | −0.22‡ |
|
| 0.09 | 0.10 | 0.08 | 0.08 | 0.10 | 0.12 | 0.13 | 0.14 | 0.09 | 0.12 | 0.10 | 0.09 | |
| TC (mg/dL) |
| 0.003‡ | 0.004‡ | 0.004‡ | 0.003** | 0.003‡ | 0.002** | 0.003** | 0.004** | 0.002** | 0.003** | 0.002** | 0.002** |
|
| 0.09 | 0.11 | 0.09 | 0.08 | 0.08 | 0.07 | 0.08 | 0.07 | 0.05 | 0.08 | 0.06 | 0.05 | |
| HDL (mg/dL) |
| 0.09 | 0.15 | 0.13 | 0.09 | 0.10 | 0.08 | 0.13 | 0.24 | 0.08 | 0.15 | 0.10 | 0.06 |
|
| 0.004 | 0.009 | 0.005 | 0.005 | 0.004 | 0.006 | 0.01 | 0.01 | 0.003 | 0.01 | 0.005 | 0.002 | |
| LDL (mg/dL) |
| 0.004** | 0.005** | 0.004** | 0.004 | 0.004** | 0.003** | 0.003** | 0.005** | 0.003* | 0.004** | 0.003* | 0.003* |
|
| 0.07 | 0.08 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.07 | 0.05 | 0.05 | |
| TG (mg/dL) |
| 0.006** | 0.006** | 0.008‡ | 0.004* | 0.006** | 0.003 | 0.004* | 0.004 | 0.004* | 0.003 | 0.005* | 0.004* |
|
| 0.06 | 0.06 | 0.09 | 0.04 | 0.06 | 0.04 | 0.04 | 0.02 | 0.03 | 0.02 | 0.04 | 0.04 | |
| TC/HDL |
| 0.002 | 0.002 | 0.002 | 0.001 | 0.002 | 0.001 | 0.001 | 0.002 | 0.002 | 0.001 | 0.002 | 0.002 |
|
| 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.006 | 0.02 | 0.01 | 0.02 | 0.02 | |
| LDL/HDL |
| 0.003 | 0.003 | 0.003 | 0.002 | 0.003 | 0.002 | 0.002 | 0.003 | 0.003 | 0.002 | 0.002 | 0.002 |
|
| 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.001 | 0.02 | 0.02 | 0.01 | 0.02 | |
| Uric Acid (mg/dL) |
| −0.08‡ | −0.09‡ | −0.09‡ | −0.08‡ | −0.09‡ | −0.07‡ | −0.08‡ | −0.14‡ | −0.09‡ | −0.09‡ | −0.09‡ | −0.08‡ |
|
| 0.31 | 0.31 | 0.26 | 0.33 | 0.32 | 0.39 | 0.38 | 0.39 | 0.29 | 0.40 | 0.35 | 0.32 | |
| Insulin ( |
| −0.1‡ | −0.01‡ | −0.1‡ | −0.1‡ | −0.01‡ | −0.008‡ | −0.01‡ | −0.02‡ | −0.01‡ | −0.01‡ | −0.01‡ | −0.01‡ |
|
| 0.31 | 0.31 | 0.25 | 0.33 | 0.31 | 0.39 | 0.37 | 0.39 | 0.28 | 0.40 | 0.34 | 0.31 | |
| HOMA-IR |
| 0.008‡ | 0.009‡ | 0.01‡ | 0.006** | 0.008‡ | 0.005** | 0.006** | 0.008* | 0.008‡ | 0.004* | 0.008‡ | 0.006** |
|
| 0.10 | 0.09 | 0.13 | 0.07 | 0.10 | 0.08 | 0.08 | 0.04 | 0.08 | 0.04 | 0.09 | 0.08 | |
| SBP (mmHg) |
| −0.36‡ | −0.35‡ | −0.36** | −0.32‡ | −0.35‡ | −0.28‡ | −0.34‡ | −0.56‡ | −0.32** | −0.31 | −0.37‡ | −0.33‡ |
|
| 0.12 | 0.09 | 0.08 | 0.09 | 0.09 | 0.13 | 0.12 | 0.13 | 0.08 | 0.09 | 0.12 | 0.11 | |
| DBP (mmHg) |
| 0.25** | 0.34** | 0.33** | 0.30‡ | 0.33‡ | 0.20** | 0.27** | 0.36** | 0.32** | 0.28** | 0.26** | 0.27** |
|
| 0.06 | 0.09 | 0.07 | 0.09 | 0.09 | 0.07 | 0.08 | 0.05 | 0.08 | 0.08 | 0.06 | 0.08 |
BIA1: tetra-polar horizontal electrical bioimpedance analysis; BIA2: tetra-polar vertical electrical bioimpedance analysis using 8-point tactile electrode; Eq: equation; TC: total cholesterol; TG: triglycerides; HDL: high-density lipoprotein; LDL: low-density lipoprotein; HOMA-IR: homeostasis model assessment-insulin resistance; SBP: systolic blood pressure; DBP: diastolic blood pressure; β: coefficient of linear regression; r 2: coefficient of determination; *P < 0.05; **P < 0.001; ‡ P < 0.0001.
Multiple linear regression coefficient (β) and coefficient of determination (R 2) of the relationship between percentage of body fat, adjusted for sex and normal individuals with excess body fat, and biochemical and clinical parameters in eutrophic adolescents (G1) (Viçosa, Minas Gerais, Brazil (2010)).
| Eq (1) | Eq (2) | Eq (3) | Eq (4) | Eq (5) | Eq (6) | Eq (7) | Eq (8) | Eq (9) | Eq (10) | BIA1 | BIA2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fasting glucose (mg/dL) |
| 0.21 | 0.11 | — | 0.21 | 0.28 | 0.11 | 0.13 | −0.29 | 0.08 | — | 0.22 | 0.25 |
|
| 0.18 | 0.17 | 0.18 | 0.18 | 0.17 | 0.17 | 0.19 | 0.17 | 0.17 | 0.18 | |||
| TC (mg/dL) |
| 0.002 | 0.003 | 0.003 | 0.0007 | 0.004 | −0.002 | 0.001 | −0.001 | −0.003 | 0.002 | 0.0001 | −0.003 |
|
| 0.09 | 0.11 | 0.10 | 0.09 | 0.10 | 0.11 | 0.08 | 0.08 | 0.09 | 0.09 | 0.08 | 0.10 | |
| LDL (mg/dL) |
| 0.004 | 0.004 | 0.003 | 0.003 | 0.007 | −0.0007 | 0.003 | −0.0005 | −0.001 | 0.004 | 0.0008 | −0.002 |
|
| 0.07 | 0.08 | 0.07 | 0.07 | 0.08 | 0.07 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | 0.07 | |
| TG (mg/dL) |
| — | 0.02‡ | 0.02‡ | 0.008 | 0.02‡ | — | — | — | −0.004 | — | 0.01 | 0.001 |
|
| 0.11 | 0.12 | 0.04 | 0.11 | 0.08 | 0.05 | 0.06 | ||||||
| Insulin ( |
| — | — | 0.003 | 0.003 | 0.01** | — | — | — | — | — | 0.001 | 0.003 |
|
| 0.49 | 0.49 | 0.51 | 0.49 | 0.49 | ||||||||
| HOMA-IR |
| — | — | — | 0.01** | — | — | — | — | — | — | — | — |
|
| 0.09 | ||||||||||||
| SBP (mmHg) |
| 0.03 | 0.24 | 0.002 | 0.13 | 0.33 | −0.02 | 0.14 | 0.01 | 0.22 | 0.43 | −0.17 | −0.02 |
|
| 0.15 | 0.15 | 0.15 | 0.15 | 0.16 | 0.15 | 0.15 | 0.15 | 0.15 | 0.18 | 0.15 | 0.15 | |
| DBP (mmHg) |
| −0.01 | 0.16 | 0.20 | 0.37 | 0.74** | 0.11 | 0.36 | −0.13 | 0.29 | 0.14 | 0.19 | 0.28 |
|
| 0.05 | 0.09 | 0.07 | 0.09 | 0.12 | 0.08 | 0.08 | 0.05 | 0.08 | 0.09 | 0.07 | 0.06 |
Note. HDL, TC/HDL, LDL/HDL, and uric acid did not meet the assumptions of linear regression. BIA1: tetra-polar horizontal electrical bioimpedance analysis; BIA2: tetra-polar vertical electrical bioimpedance analysis using 8-point tactile electrode; Eq: equation; TC: total cholesterol; TG: triglycerides; LDL: low-density lipoprotein; HOMA-IR: homeostasis model assessment-insulin resistance; SBP: systolic blood pressure; DBP: diastolic blood pressure; β: coefficient of multiple linear regression, R 2: coefficient of determination, —: did not meet the assumptions of linear regression; *P < 0.05; **P < 0.001; ‡ P < 0.0001.
Simple linear regression coefficient (β) and coefficient of determination (r 2) of the relationship between percentage of body fat and biochemical and clinical parameters in overweight adolescents (G2) (Viçosa, Minas Gerais, Brazil (2010)).
| Eq (1) | Eq (2) | Eq (3) | Eq (4) | Eq (5) | Eq (6) | Eq (7) | Eq (8) | Eq (9) | Eq (10) | BIA1 | BIA2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fasting glucose (mg/dL) |
| 0.19 | 0.13 | 0.16* | 0.17 | 0.22 | 0.08 | 0.04 | 0.15 | 0.13 | 0.13 | 0.18 | 0.06 |
|
| 0.03 | 0.01 | 0.06 | 0.005 | 0.03 | 0.01 | 0.002 | 0.02 | 0.01 | 0.02 | 0.03 | 0.005 | |
| TC (mg/dL) |
| 0.004** | 0.0003 | 0.002** | 0.004‡ | 0.006** | 0.003** | 0.003** | 0.004** | 0.006‡ | 0.004** | 0.005 | 0.004 |
|
| 0.12 | 0.00 | 0.11 | 0.17 | 0.16 | 0.14 | 0.12 | 0.11 | 0.18 | 0.12 | 0.16 | 0.17 | |
| HDL (mg/dL) |
| 0.41* | 0.58* | 0.08 | 0.25 | 0.47* | 0.37** | 0.42** | 0.34 | 0.56* | 0.46* | 0.46* | 0.30 |
|
| 0.06 | 0.06 | 0.006 | 0.04 | 0.06 | 0.11 | 0.11 | 0.04 | 0.08 | 0.09 | 0.08 | 0.04 | |
| LDL (mg/dL) |
| 0.74 | −0.36 | 0.50* | 0.62* | 1.03* | 0.46 | 0.50 | 0.81 | 1.08* | 0.63 | 0.80 | 0.87* |
|
| 0.04 | 0.01 | 0.06 | 0.06 | 0.07 | 0.04 | 0.04 | 0.05 | 0.07 | 0.04 | 0.06 | 0.09 | |
| TG (mg/dL) |
| 0.007 | −0.002 | 0.006** | 0.007* | 0.01* | 0.004 | 0.003 | 0.006 | 0.01* | 0.004 | 0.008* | 0.006 |
|
| 0.04 | 0.001 | 0.10 | 0.08 | 0.06 | 0.03 | 0.01 | 0.02 | 0.06 | 0.02 | 0.06 | 0.04 | |
| TC/HDL |
| 0.000 | −0.006 | 0.001 | 0.001 | 0.001 | −0.001 | −0.001 | 0.001 | 0.0002 | −0.001 | 0.000 | 0.001 |
|
| 0.000 | 0.05 | 0.02 | 0.003 | 0.001 | 0.005 | 0.005 | 0.002 | 0.0001 | 0.002 | 0.000 | 0.006 | |
| LDL/HDL |
| −0.006 | −0.04* | 0.004 | −0.002 | −0.002 | −0.009 | −0.008 | 0.002 | −0.006 | −0.008 | −0.008 | 0.004 |
|
| 0.003 | 0.06 | 0.04 | 0.0004 | 0.0004 | 0.01 | 0.01 | 0.0002 | 0.002 | 0.006 | 0.005 | 0.002 | |
| Uric Acid (mg/dL) |
| −0.02 | −0.07* | 0.03* | 0.01 | −0.02 | −0.03* | −0.05** | −0.02 | −0.03 | −0.04* | −0.03 | −0.01 |
|
| 0.01 | 0.06 | 0.08 | 0.01 | 0.009 | 0.07 | 0.13 | 0.02 | 0.02 | 0.06 | 0.02 | 0.005 | |
| Insulin ( |
| 0.008* | 0.01** | 0.006* | 0.008** | 0.01* | 0.004 | 0.004 | 0.01* | 0.01** | 0.008* | 0.01** | 0.006* |
|
| 0.07 | 0.11 | 0.09 | 0.13 | 0.09 | 0.05 | 0.02 | 0.09 | 0.01 | 0.08 | 0.10 | 0.06 | |
| HOMA-IR |
| 0.01* | 0.02** | 0.006** | 0.009** | 0.01* | 0.005 | 0.004 | 0.01* | 0.01* | 0.009* | 0.01** | 0.006 |
|
| 0.08 | 0.10 | 0.10 | 0.13 | 0.09 | 0.05 | 0.02 | 0.08 | 0.09 | 0.07 | 0.10 | 0.05 | |
| SBP (mmHg) |
| −0.14 | −0.28 | 0.04 | −0.003 | −0.11 | −0.18 | −0.14 | −0.14 | −0.38 | −0.08 | −0.29 | −0.27 |
|
| 0.009 | 0.02 | 0.002 | 0.00 | 0.004 | 0.04 | 0.02 | 0.009 | 0.05 | 0.004 | 0.04 | 0.05 | |
| DBP (mmHg) |
| 0.38* | 0.14 | 0.10 | 0.19 | 0.43* | 0.24* | 0.36** | 0.54** | 0.55** | 0.55‡ | 0.45** | 0.42** |
|
| 0.07 | 0.005 | 0.10 | 0.04 | 0.08 | 0.07 | 0.12 | 0.14 | 0.12 | 0.18 | 0.12 | 0.14 |
BIA1: tetra-polar horizontal electrical bioimpedance analysis; BIA2: tetra-polar vertical electrical bioimpedance analysis using 8-point tactile electrode; Eq: equation, TC: total cholesterol; TG: triglycerides; HDL: high-density lipoprotein; LDL: low-density lipoprotein; HOMA-IR: homeostasis model assessment-insulin resistance; SBP: systolic blood pressure; DBP: diastolic blood pressure; β: coefficient of linear regression; r 2: coefficient of determination; *P < 0.05; **P < 0.001; ‡ P < 0.0001.
Multiple linear regression coefficient (β) and coefficient of determination (R 2) of the relationship between percentage of body fat, adjusted for sex, and biochemical and clinical parameters in overweight adolescents (G2) (Viçosa, Minas Gerais, Brazil (2010)).
| Eq (1) | Eq (2) | Eq (3) | Eq (4) | Eq (5) | Eq (6) | Eq (7) | Eq (8) | Eq (9) | Eq (10) | BIA1 | BIA2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fasting glucose (mg/dL) |
| — | — | 0.16 | — | — | — | — | — | — | — | — | — |
|
| 0.06 | ||||||||||||
| TC (mg/dL) |
| 0.004 | −0.002 | — | — | — | 0.004* | — | 0.004 | 0.007** | 0.005 | — | 0.004** |
|
| 0.12 | 0.09 | 0.14 | 0.11 | 0.18 | 0.12 | 0.17 | ||||||
| HDL (mg/dL) |
| −0.20 | 0.23 | — | — | −0.12 | 0.06 | −0.24 | −0.34 | 0.09 | −0.16 | −0.02 | — |
|
| 0.15 | 0.15 | 0.15 | 0.14 | 0.15 | 0.16 | 0.15 | 0.15 | 0.14 | ||||
| LDL (mg/dL) |
| 1.17 | −1.23 | 2.27 | 0.10 | 1.65* | 1.03 | 1.72 | — | 1.86* | 0.93 | 2.28* | — |
|
| 0.05 | 0.04 | 0.12 | 0.13 | 0.08 | 0.06 | 0.07 | 0.09 | 0.05 | 0.12 | |||
| TG (mg/dL) |
| — | — | 0.007** | 0.007* | 0.02** | — | — | — | 0.02** | — | 0.02* | — |
|
| 0.11 | 0.08 | 0.12 | 0.11 | 0.13 | ||||||||
| Uric Acid (mg/dL) |
| — | −0.007 | — | — | — | 0.08** | 0.13** | — | — | 0.12** | — | — |
|
| 0.26 | 0.37 | 0.37 | 0.39 | |||||||||
| Insulin ( |
| 0.02** | — | 0.006* | 0.008** | 0.02** | — | — | 0.02** | 0.02** | 0.02** | 0.02** | 0.009* |
|
| 0.11 | 0.09 | 0.13 | 0.14 | 0.13 | 0.13 | 0.17 | 0.17 | 0.07 | ||||
| HOMA-IR |
| 0.02** | — | 0.006* | 0.009** | 0.02** | — | — | 0.02** | 0.02** | 0.02** | — | 0.009* |
|
| 0.12 | 0.10 | 0.13 | 0.14 | 0.12 | 0.12 | 0.16 | 0.07 | |||||
| DBP (mmHg) |
| 0.05 | — | — | — | 0.11 | −0.03 | 0.27 | 0.40 | 0.34 | 0.66* | 0.28 | 0.31 |
|
| 0.11 | 0.11 | 0.11 | 0.12 | 0.15 | 0.14 | 0.19 | 0.13 | 0.15 |
Note. TC/HDL, LDL/HDL, and SBP did not meet the assumptions of linear regression. BIA1: tetra-polar horizontal electrical bioimpedance analysis; BIA2: tetra-polar vertical electrical bioimpedance analysis using 8-point tactile electrode; Eq: equation; TC: total cholesterol; TG: triglycerides; HDL: high-density lipoprotein; LDL: low-density lipoprotein; HOMA-IR: homeostasis model assessment-insulin resistance; DBP: diastolic blood pressure; β: coefficient of linear regression; R 2: coefficient of determination; —: did not meet the assumptions of linear regression; *P < 0.05; **P < 0.001; ‡ P < 0,0001.